Materias dentro de su búsqueda.
Mostrando 15,101 - 15,120 Resultados de 15,180 Para Buscar '"Hepatitis C"', tiempo de consulta: 0.51s Limitar resultados
  1. 15101
    “…Among blood-borne virus infections there were six cases of particular note: three cases of acute hepatitis following hepatitis C virus infection with a short period of incubation, one laboratory case of human immunodeficiency virus infection through aerosol inhalation, one case of hepatitis following hepatitis G virus infection, and one case of fulminant hepatitis with hepatitis B virus infection following exposure of the worker's conjunctiva to hepatitis B virus e antigen-negative patient saliva. …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    Viral infections in workers in hospital and research laboratory settings: a comparative review of infection modes and respective biosafety aspects
  2. 15102
    “…Background and objectives Chronic liver disease (CLD) encompasses a variety of etiologies, and the infectious causes are mainly hepatitis B and hepatitis C virus. Chronic alcohol abuse and non-alcoholic fatty liver disease also have a major contribution to CLD. …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    Severity of Non-B and Non-C Hepatitis Versus Hepatitis B and C Associated Chronic Liver Disease: A Retrospective, Observational, Comparative Study
  3. 15103
    “…IMPORTANCE: People with HIV (PWH) are often coinfected with hepatitis B virus (HBV) and/or hepatitis C virus (HCV), leading to increased risk of developing hepatocellular carcinoma (HCC), but few cohort studies have had sufficient power to describe the trends of HCC incidence and risk among PWH in the combination antiretroviral therapy (cART) era. …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    Trends in Hepatocellular Carcinoma Incidence and Risk Among Persons With HIV in the US and Canada, 1996-2015
  4. 15104
    “…Models included age, sex, race or ethnicity, prevalent heart failure, chronic obstructive pulmonary disease, hypertension, smoking status, diabetes, body-mass index, estimated glomerular filtration rate, hepatitis C virus infection, liver cirrhosis, and drug use as covariates. …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    Association between HIV and incident pulmonary hypertension in US Veterans: a retrospective cohort study
  5. 15105
    “…Mean age was 50.3 (SD 12.4), of which 58.1% were women. 15.4% showed metabolic syndrome (NCEP ATP‐III), 1.3% were positive for hepatitis C antibodies, 0.8% positive for HBsAg, 9.1% reported harmful use of alcohol. …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    High liver stiffness values by transient elastography related to metabolic syndrome and harmful alcohol use in a large Spanish cohort
  6. 15106
    “…BACKGROUND: The phase IIIb ATLAS-2M study demonstrated non-inferiority of long-acting (LA) cabotegravir (CAB) + rilpivirine (RPV) dosed every 8 weeks (Q8W) compared with every 4 weeks (Q4W) for maintenance of virologic suppression. Hepatitis C virus (HCV) co-infection occurs in ~6% of people with HIV due to shared modes of transmission. …”
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    833. Efficacy and Safety of Long-Acting Cabotegravir + Rilpivirine in Participants with HIV/HCV Co-infection: ATLAS-2M 48-Week Results
  7. 15107
    “…METHODS: We employed population-wide electronic health records (EHRs; from 1998 to 2020) consisting of almost 4 million adults to assess regional variations in disease burden of five liver conditions, alcoholic liver disease (ALD), autoimmune liver disease, chronic hepatitis B infection (HBV), chronic hepatitis C infection (HCV) and NAFLD, in England. We analysed regional differences in incidence rates for 17 manifestations of CVD in people with or without liver disease. …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    Increased burden of cardiovascular disease in people with liver disease: unequal geographical variations, risk factors and excess years of life lost
  8. 15108
    “…BACKGROUND: Porphyria cutanea tarda (PCT) is a skin disorder caused by a defect in the liver enzyme uroporphyrinogen decarboxylase and is associated with hepatitis C virus infection, high alcohol intake, smoking and iron overload. …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    Porphyria cutanea tarda and patterns of long-term sick leave and disability pension: a 24-year nationwide matched-cohort study
  9. 15109
    “…BACKGROUND: Hepatitis C virus infection is the main cause of liver ailments across the globe. …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    Hesperidin identified from Citrus extracts potently inhibits HCV genotype 3a NS3 protease
  10. 15110
    “…Eligibility criteria for these RCTs included no history of treatment failure or any major nucleoside reverse transcriptase inhibitor or integrase inhibitor–associated mutations, no hepatitis B virus (HBV) or need for hepatitis C virus (HCV) therapy, and viral load (VL) < 500,000 c/mL at screening (GEMINI) or < 50 c/mL for > 6 months (TANGO, SALSA). …”
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    1285. Systematic Literature Review of Real-world Experience with the 2-Drug Regimen Dolutegravir and Lamivudine in People with HIV Who Would Not Have Met Inclusion Criteria for the Phase 3 Clinical Program
  11. 15111
    “…BACKGROUND: Among people who inject drugs (PWID), obtaining syringes via syringe services programs (SSPs) and pharmacies reduces injection sharing practices associated with hepatitis C virus (HCV). Whether indirect use of SSPs via secondary exchange confers a similar benefit remains unknown, particularly in rural settings. …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    HCV serostatus and injection sharing practices among those who obtain syringes from pharmacies and directly and indirectly from syringe services programs in rural New England
  12. 15112
    “…We aimed to assess plasma homo sapiens—(hsa)-miR-21-5p, hsa-miR-155-5p, hsa-miR-192-5p, and hsa-miR-199a-5p—expression levels as a panel of biomarkers for HCC in chronic hepatitis C virus (CHCV) patients with liver cirrhosis (LC), especially AFP-negative HCC cases, as a step toward non-protein coding (nc) RNA precision medicine. …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    Diagnostic Significance of hsa-miR-21-5p, hsa-miR-192-5p, hsa-miR-155-5p, hsa-miR-199a-5p Panel and Ratios in Hepatocellular Carcinoma on Top of Liver Cirrhosis in HCV-Infected Patients
  13. 15113
    “…The secondary objectives are to (1) examine differences between PrEP care modalities regarding incidences of STIs, HIV infection, and hepatitis C virus infection; retention in PrEP care; intracellular tenofovir-diphosphate concentration; and satisfaction, usability, and acceptability of PrEP care modalities; and (2) evaluate associations of these study outcomes with sociodemographic, behavioral, and psychological characteristics. …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    Online-Mediated HIV Pre-exposure Prophylaxis Care and Reduced Monitoring Frequency for Men Who Have Sex With Men: Protocol for a Randomized Controlled Noninferiority Trial (EZI-PrEP Study)
  14. 15114
    por Akinyemiju, Tomi, Abera, Semaw, Ahmed, Muktar, Alam, Noore, Alemayohu, Mulubirhan Assefa, Allen, Christine, Al-Raddadi, Rajaa, Alvis-Guzman, Nelson, Amoako, Yaw, Artaman, Al, Ayele, Tadesse Awoke, Barac, Aleksandra, Bensenor, Isabela, Berhane, Adugnaw, Bhutta, Zulfiqar, Castillo-Rivas, Jacqueline, Chitheer, Abdulaal, Choi, Jee-Young, Cowie, Benjamin, Dandona, Lalit, Dandona, Rakhi, Dey, Subhojit, Dicker, Daniel, Phuc, Huyen, Ekwueme, Donatus U., Zaki, Maysaa El Sayed, Fischer, Florian, Fürst, Thomas, Hancock, Jamie, Hay, Simon I., Hotez, Peter, Jee, Sun Ha, Kasaeian, Amir, Khader, Yousef, Khang, Young-Ho, Kumar, G Anil, Kutz, Michael, Larson, Heidi, Lopez, Alan, Lunevicius, Raimundas, Malekzadeh, Reza, McAlinden, Colm, Meier, Toni, Mendoza, Walter, Mokdad, Ali, Moradi-Lakeh, Maziar, Nagel, Gabriele, Nguyen, Quyen, Nguyen, Grant, Ogbo, Felix, Patton, George, Pereira, David M., Pourmalek, Farshad, Qorbani, Mostafa, Radfar, Amir, Roshandel, Gholamreza, Salomon, Joshua A, Sanabria, Juan, Sartorius, Benn, Satpathy, Maheswar, Sawhney, Monika, Sepanlou, Sadaf, Shackelford, Katya, Shore, Hirbo, Sun, Jiandong, Mengistu, Desalegn Tadese, Topór-Mądry, Roman, Tran, Bach, Ukwaja, Kingsley Nnanna, Vlassov, Vasiliy, Vollset, Stein Emil, Vos, Theo, Wakayo, Tolassa, Weiderpass, Elisabete, Werdecker, Andrea, Yonemoto, Naohiro, Younis, Mustafa, Yu, Chuanhua, Zaidi, Zoubida, Zhu, Liguo, Murray, Christopher J. L., Naghavi, Mohsen, Fitzmaurice, Christina
    Publicado 2017
    “…The most common causes for liver cancer include hepatitis B virus (HBV) and hepatitis C virus (HCV) infection and alcohol use. OBJECTIVE: To report results of the Global Burden of Disease (GBD) 2015 study on primary liver cancer incidence, mortality, and disability-adjusted life-years (DALYs) for 195 countries or territories from 1990 to 2015, and present global, regional, and national estimates on the burden of liver cancer attributable to HBV, HCV, alcohol, and an “other” group that encompasses residual causes. …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    The Burden of Primary Liver Cancer and Underlying Etiologies From 1990 to 2015 at the Global, Regional, and National Level: Results From the Global Burden of Disease Study 2015
  15. 15115
    Publicado 2020
    “…All estimates are presented for five causes of cirrhosis: hepatitis B, hepatitis C, alcohol-related liver disease, non-alcoholic steatohepatitis (NASH), and other causes. …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    The global, regional, and national burden of cirrhosis by cause in 195 countries and territories, 1990–2017: a systematic analysis for the Global Burden of Disease Study 2017
  16. 15116
    “…METHODS: This dose-escalation, open-label, non-randomised, uncontrolled, phase 1 trial was done at the Centre for Clinical Vaccinology and Tropical Medicine (Oxford, UK) and included healthy people aged 18–50 years with negative pre-vaccination tests for HIV antibodies, hepatitis B surface antigen, and hepatitis C antibodies (and a negative urinary pregnancy test for women). …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    Safety and immunogenicity of a candidate Middle East respiratory syndrome coronavirus viral-vectored vaccine: a dose-escalation, open-label, non-randomised, uncontrolled, phase 1 trial
  17. 15117
    “…PARTICIPANTS: All COVID-19 patients admitted to Shahid Mohammadi Hospital in Bandar Abbas whose PCR test results are positive for SARS-Cov-2 and sign the written consent of the study are included in the study and immunocompromised patients, end-stage renal disease, moderate renal failure (clearance Creatinine 30 to 50 ml/min) or stage 4 severe chronic kidney disease or need for dialysis (creatinine clearance lesser than 30 ml/min), history of liver disease, hepatitis C infection or alcoholism, Glucose 6 phosphate dehydrogenase deficiency(G6PD), the ratio of Alanine transaminase to Aspartate transaminase 5 times above the normal limit, history or evidence of long QT segment on Electrocardiogram, psoriasis or porphyria, pregnancy, use of oral contraceptives, Dasatinib, Neratinib, Ozanimod, Pazopanib, Rilpivirine, Siponimod and/or Tizanidine and allergies to any study drug are excluded. …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    The Efficacy of Famotidine in improvement of outcomes in Hospitalized COVID-19 Patients: A structured summary of a study protocol for a randomised controlled trial
  18. 15118
    “…Real-time PCR was used for detecting 20 different viral agents other than EVs (six herpesviruses, human polyomavirus [BK virus and JC virus], parvovirus B19, hepatitis B virus, hepatitis C virus, hepatitis A virus, mumps, rubella, influenza A/B, parainfluenza 1–4, respiratory syncytial virus, astrovirus, norovirus, rotavirus). …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    Live enteroviruses, but not other viruses, detected in human pancreas at the onset of type 1 diabetes in the DiViD study
  19. 15119
    Publicado 2007
    Tabla de Contenidos: “…Rice -- Flaviviruses / Duane Gubler, Goro Kuno, and Lewis Markoff -- Hepatitis C virus / Stanley M. Lemon ... [et al.] -- Coronaviridae / Michael M.C. …”
    Tabla de contenido
    Software Libro
    Fields virology /
  20. 15120
    “…BACKGROUND: Previous research has shown that hemophilia patients infected in the 1980s with human immunodeficiency virus (HIV) and/or hepatitis C virus (HCV) from the blood supply have increased morbidity and mortality. …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    Medical Costs and Resource Utilization for Hemophilia Patients With and Without HIV or HCV Infection
Herramientas de búsqueda: RSS